To include your compound in the COVID-19 Resource Center, submit it here.
Cancer companies Oncternal and Tokalas merged and will retain the Oncternal name. Oncternal’s cirmtuzumab (UC-961), a humanized
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury